Off Our Chests: Dr. John Marshall, Wife Liza Get ‘Candid’ About Triple-Negative Breast Cancer
Ahead of the release of their book, “Off Our Chests”, Dr. John Marshall and his wife, Liza, look back on the trials and tribulations of Liza’s triple-negative breast cancer diagnosis – from the perspective of a patient and her husband, the caregiver and oncologist.
A breast cancer diagnosis can come as a shock to anyone. Now, imagine the news also coming from your husband, an oncologist in the gastrointestinal cancer space – turning both of your worlds upside down.
The lives of Dr. John Marshall and his wife, Liza, were changed in November 2006, when the matriarch of the Marshall family was diagnosed with stage 3 triple-negative breast cancer. The pair tackled a new obstacle as Liza began treatment, and John – who is chief of the Division of Hematology/Oncology at Medstar Georgetown University Hospital, professor of medicine and oncology and director at the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer at Georgetown-Lombardi Comprehensive Cancer Center – played a new role in the oncology world: caregiver.
In the book “Off our Chests: A Candid Tour Through the World of Cancer,” both John and Liza Marshall alternate sharing their perspectives on this challenging time. CURE and OncLive sat down with John and Liza to go beyond the pages in the book, as the couple discussed their journey – both together and separately – as well as the deep appreciation they now have for other patients and their oncologists.
“Off Our Chests: A Candid Tour Through the World of Cancer” will be released in hardcover format on April 6, 2021. Click here to pre-order.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Listen
